These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 4310618)

  • 1. Non-identity between pulmonary bradykininase and converting-enzyme activity.
    Scholz HW; Biron P
    Rev Can Biol; 1969 Sep; 28(3):197-200. PubMed ID: 4310618
    [No Abstract]   [Full Text] [Related]  

  • 2. Converting enzyme and bradykininase in the lung.
    Alabaster VA; Bakhle YS
    Circ Res; 1972 Sep; 31(9):Suppl 2:72-84. PubMed ID: 4341482
    [No Abstract]   [Full Text] [Related]  

  • 3. The bradykininase activities of extracts of dog lung.
    Alabaster VA; Bakhle YS
    Br J Pharmacol; 1973 Apr; 47(4):799-807. PubMed ID: 4723801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo pulmonary metabolism of bradykinin, angiotensin I and 5-hydroxtryptamine in the rat.
    Freer RJ; Stewart JM
    Arch Int Pharmacodyn Ther; 1975 Sep; 217(1):97-109. PubMed ID: 172037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inactivation of bradykinin in the pulmonary circulation of isolated lungs.
    Alabaster VA; Bakhle YS
    Br J Pharmacol; 1972 Jun; 45(2):299-310. PubMed ID: 4625922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of Z13752A, a combined ACE/NEP inhibitor, on responses to coronary artery occlusion; a primary protective role for bradykinin.
    Rastegar MA; Marchini F; Morazzoni G; Vegh A; Papp JG; Parratt JR
    Br J Pharmacol; 2000 Feb; 129(4):671-80. PubMed ID: 10683191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary angiotensin-converting enzyme. Interspecies homology and inhibition by heterologous antibody in vivo.
    Conroy JM; Hoffman H; Kirk ES; Hirzel HO; Sonnenblick EH; Soffer RL
    J Biol Chem; 1976 Aug; 251(16):4828-32. PubMed ID: 182680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of a role of circulating bradykinin in the blood pressure response to acute angiotensin converting enzyme inhibition in rats.
    Aubert JF; Waeber B; Nussberger J; Vavrek R; Stewart JM; Brunner HR
    Agents Actions Suppl; 1987; 22():349-54. PubMed ID: 3324717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of reduced angiotensin-converting enzyme gene expression and angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptide levels in mice.
    Campbell DJ; Alexiou T; Xiao HD; Fuchs S; McKinley MJ; Corvol P; Bernstein KE
    Hypertension; 2004 Apr; 43(4):854-9. PubMed ID: 14769811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between the kininase and angiotensin-converting lung functions in rabbits with cerebroischemic and renovascular hypertension].
    Karpitskiĭ VV; Gomazkov OA
    Biull Eksp Biol Med; 1982 Jan; 93(1):24-6. PubMed ID: 6279206
    [No Abstract]   [Full Text] [Related]  

  • 11. Gynura procumbens causes vasodilation by inhibiting angiotensin II and enhancing bradykinin actions.
    Poh TF; Ng HK; Hoe SZ; Lam SK
    J Cardiovasc Pharmacol; 2013 May; 61(5):378-84. PubMed ID: 23328388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin I [Phe8-His9] hydrolase and bradykininase from human lung.
    Overturf M; Wyatt S; Boaz D; Fitz A
    Life Sci; 1975 Jun; 16(11):1669-81. PubMed ID: 167251
    [No Abstract]   [Full Text] [Related]  

  • 13. Some properties of angiotensin converting enzyme in the lung in vivo.
    Ng KK; Vane JR
    Nature; 1970 Mar; 225(5238):1142-4. PubMed ID: 4313869
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of a fibrin-derived vasoactive peptide on pulmonary angiotensin converting enzyme activity and on pressure responses to bradykinin.
    Moalli R; Saldeen K; Saldeen T
    J Pharmacol Exp Ther; 1987 Dec; 243(3):897-900. PubMed ID: 3694536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion of angiotensin I to angiotensin II by cell-free extracts of dog lung.
    Bakhle YS
    Nature; 1968 Nov; 220(5170):919-21. PubMed ID: 4301850
    [No Abstract]   [Full Text] [Related]  

  • 16. Angiotensin antogonists as pharmacological tools.
    Needleman P; Douglas JR; Jakschik BA; Blumberg AL; Isakson PC; Marshall GR
    Fed Proc; 1976 Nov; 35(13):2488-93. PubMed ID: 185093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of the intraventricular administration of angiotensin II, bradykinin and eledoisin on the arterial blood pressure, respiratory movements and electrocardiogram.
    Cuparencu B; Ticşa I; Safta L; Csutak V; Mocan R
    Rev Roum Physiol; 1969; 6(3):213-20. PubMed ID: 4323315
    [No Abstract]   [Full Text] [Related]  

  • 18. Participation of prostaglandins and bradykinin in the effects of angiotensin II and converting enzyme-inhibition on sympathetic neurotransmission in vivo.
    Schwieler JH; Kahan T; Nussberger J; Hjemdahl P
    Acta Physiol Scand; 1994 Sep; 152(1):83-91. PubMed ID: 7810335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the potentiation of kinins by sulfhydrylic compounds.
    Auerswald W; Doleschel W
    Arch Int Pharmacodyn Ther; 1967 Jul; 168(1):188-98. PubMed ID: 4292761
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats.
    Gonzalez Vera W; Fournié-Zaluski MC; Pham I; Laboulandine I; Roques BP; Michel JB
    J Pharmacol Exp Ther; 1995 Jan; 272(1):343-51. PubMed ID: 7815350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.